Local excision for middle-low rectal cancer after neoadjuvant chemoradiation: A retrospective study from a single tertiary center

Table 1 Clinicopathological characteristics of 33 patients

Variables	n (%) or median (range)
Age (years)	61.0 (28.0-75.0)
Gender
Male	16 (48.5)
Female	17 (51.5)
Diameter of lesion (cm)	2.0 (1.0-3.0)
Distance from the anal verge (cm)	3.0 (1.0-10.0)
cT baseline
1	0 (0.0)
2	9 (27.3)
3	19 (57.6)
4	5 (15.2)
cN baseline
Negative	8 (24.2)
Positive	25 (75.8)
cM baseline
M0	31 (93.9)
M1	2 (6.1)
ycT
0	21 (63.6)
1	5 (15.2)
2	6 (18.2)
3	1 (3.0)
4	0 (0.0)
ypT
0	18 (54.5)
1	6 (18.2)
2	7 (21.2)
3	2 (6.1)
4	0 (0.0)
Differentiation
G1	3 (9.1)
G2	29 (87.9)
G3	1(3.0)
Baseline CEA
Normal	32 (97.0)
Abnormal	1 (3.0)
Interval between NCRT and surgery (week)	25.4 (8.7-164.4)
Chemotherapy
Cap	13 (39.4)
CapeOx	20 (60.6)
Surgical duration (minute)	57.0 (20.0-137.0)
Blood loss (mL)	10.0 (5.0-50.0)
Postoperative hospital stay (days)	4.0 (1.0-11.0)
Complication
No complication	26 (78.8)
With complication	7 (21.2)
CD grade
Grade I	1 (3)
Grade II	6 (18.2)
Grade III-IV	0 (0.0)
Recurrence
No	31 (93.9)
Yes	2 (6.1)
Metastasis (cM0, n = 31)
No	28 (90.3)
Yes	3 (9.7)
Follow-up time (month)	42.0 (4.0-93.5)

CEA: Carcinoembryonic antigen; NCRT: Neoadjuvant chemoradiotherapy; CD: Clavien dindo; Cap: Capecitabine; CapeOx: Capecitabine + oxaliplatin.